Increased uptake and new therapies are needed to avert rising hepatitis C-related end stage liver disease in England: Modelling the predicted impact of treatment under different scenarios

A new study from Public Health England (PHE) published in the Journal of Hepatology has looked at the cost of increasing hepatitis C treatment uptake in England, and the impact this would have on disease burden.